
Alpha Profiles · Company Profile
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics.
https://registry.alpha.ac/companies/milestone-pharmaceuticals-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: MIST
- Verification
- Partially verified
- Last reviewed
- 2026-09-18T04:46:38.512768+00:00
Overview
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-18T04:46:38.512768+00:00
